Article Information
History
- October 30, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Birgitta I. Hiddinga1,*,
- Laura A. Bolte2,3,*,
- Paul van der Leest4,
- Lucie B.M. Hijmering-Kappelle1,
- Anthonie J. van der Wekken1,
- Ed Schuuring4,
- Ranko Gacesa2,3,
- Geke A.P. Hospers5,
- Rinse K. Weersma2,
- Johannes R. Björk2,3,# and
- T Jeroen N Hiltermann1,#
- 1Dept. of Pulmonary Medicine & Tuberculosis, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands
- 2Dept. of Gastroenterology & Hepatology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands
- 3Dept. of Genetics, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands
- 4Dept. of Pathology, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands
- 5Dept. of Medical Oncology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen the Netherlands
- ↵*Corresponding author: Birgitta Hiddinga, MD. Dept. of Pulmonary Medicine & Tuberculosis, University Medical Center Groningen, Hanzeplein 1, NL - 9713 GZ Groningen, Email: b.i.hiddinga{at}umcg.nl; Tel: +31 50 361 8574
↵* contributed equally
# contributed equally
Posted October 30, 2023.
Response to immune checkpoint inhibition is associated with the gut microbiome in advanced KRAS-mutated non-small cell lung cancer
